Hybridoma technology
Understand the Problem
The question is asking about hybridoma technology, which is a method used to produce monoclonal antibodies. This technology involves the fusion of myeloma cells with antibody-producing B cells to create hybrid cells that can proliferate indefinitely while producing a specific antibody.
Answer
Hybridoma technology produces monoclonal antibodies by fusing B lymphocytes with myeloma cells.
Hybridoma technology is a method for producing monoclonal antibodies by fusing short-lived B lymphocytes with myeloma cells, creating hybrid cell lines.
Answer for screen readers
Hybridoma technology is a method for producing monoclonal antibodies by fusing short-lived B lymphocytes with myeloma cells, creating hybrid cell lines.
More Information
Hybridoma technology has revolutionized immunology and biomedical research by enabling the production of specific monoclonal antibodies, which are crucial in diagnostics and therapeutic applications.
Sources
- Hybridoma technology - Wikipedia - en.wikipedia.org
- Hybridoma Monoclonal Antibody Production - Danaher Life Sciences - lifesciences.danaher.com
- Understanding Hybridoma Technology for Monoclonal Antibody Production - the-scientist.com
AI-generated content may contain errors. Please verify critical information
